Depot buprenorphine has supplanted sublingual buprenorphine treatment in many settings in NSW, owing to its high convenience and minimal cost. People receiving methadone treatment are also often keen to transfer to buprenorphine. Recently the “Bernese”, or microdosing, method for induction onto buprenorphine from methadone shows promise, even from higher dose methadone.
In this seminar Richard Hallinan will briefly present experience from South West Sydney on uptake of depot buprenorphine to set the scene for Dr Chris Tremonti to present emerging data from a current clinical trial of microdosing versus standard care in transfers from methadone onto buprenorphine.
Dr David Jacka will present the Monash Health experience of the two depot buprenorphine products, Sublocade® and Buvidal®. Finally, in a panel discussion we will explore the hypothetical “Will methadone become second line of treatment for opioid dependence?”
These seminars are kindly sponsored by Indivior. Seminar topics are chosen solely by the Seminar Convenors (Prof Paul Haber & Dr Richard Hallinan).
Негізгі бет Sydney Addiction Seminars: Bernese or microdosing induction and the uptake of depot buprenorphine
Пікірлер: 6